Clebopride: Difference between revisions
Matt Pijoan (talk | contribs) m Protected "Clebopride": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name | | Watchedfields = changed | ||
| image | | verifiedrevid = 437179173 | ||
| | | IUPAC_name = 4-amino-''N''-(1-benzylpiperidin-4-yl)-5-chloro-<br>2-methoxybenzamide | ||
| | | image = Clebopride.png | ||
| | | image2 = Clebopride0.png | ||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|clebopride}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| | | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | ||
| | | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | ||
| pregnancy_AU | | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | ||
| pregnancy_US | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_category= | | legal_status = | ||
| legal_AU | | routes_of_administration = | ||
| legal_CA | |||
| legal_UK | <!--Pharmacokinetic data--> | ||
| legal_US | | bioavailability = | ||
| legal_status | | protein_bound = | ||
| routes_of_administration = | | metabolism = | ||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 55905-53-8 | |||
| ATC_prefix = A03 | |||
| ATC_suffix = FA06 | |||
| PubChem = 2780 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 2678 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = I0A84520Y9 | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D03534 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 325109 | |||
<!--Chemical data--> | |||
| C=20 | H=24 | Cl=1 | N=3 | O=2 | |||
| molecular_weight = 373.876 g/mol | |||
| smiles = Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3 | |||
| InChI = 1/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25) | |||
| InChIKey = BVPWJMCABCPUQY-UHFFFAOYAL | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = BVPWJMCABCPUQY-UHFFFAOYSA-N | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Clebopride''' is a [[dopamine antagonist]] drug with [[antiemetic]] and [[prokinetic]] properties used to treat functional gastrointestinal disorders. Chemically, it is a [[substituent|substituted]] [[benzamide]], closely related to [[metoclopramide]]. | '''Clebopride''' is a [[dopamine antagonist]] drug with [[antiemetic]] and [[prokinetic]] properties used to treat functional gastrointestinal disorders. Chemically, it is a [[substituent|substituted]] [[benzamide]], closely related to [[metoclopramide]]. | ||
A small Spanish study found that more [[adverse drug reaction|adverse reaction]]s are reported with clebopride than with metoclopramide, particularly [[extrapyramidal symptoms]].<ref>{{cite journal |author=Cuena Boy R, Maciá Martínez MA |title=[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System] |language=Spanish |journal=Atencion Primaria |volume=21 |issue=5 |pages=289–95 |year=1998 |pmid=9608114 |doi=}} [http://www. | A small Spanish study found that more [[adverse drug reaction|adverse reaction]]s are reported with clebopride than with metoclopramide, particularly [[extrapyramidal symptoms]].<ref>{{cite journal |author=Cuena Boy R, Maciá Martínez MA |title=[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System] |language=Spanish |journal=Atencion Primaria |volume=21 |issue=5 |pages=289–95 |year=1998 |pmid=9608114 |doi=}} [http://www.elsevier.es/revistas/ctl_servlet?_f=7064&ip=95.136.62.252&articuloid=15065&revistaid=27 Free full text]</ref> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
{{Drugs for functional gastrointestinal disorders}} | {{Drugs for functional gastrointestinal disorders}} | ||
[[Category: | [[Category:Antiemetics]] | ||
[[Category:Dopamine antagonists]] | |||
[[Category:Motility stimulants]] | |||
[[Category:Piperidines]] | |||
[[Category:Phenol ethers]] | |||
[[Category:Organochlorides]] | |||
[[Category:Drug]] |
Latest revision as of 18:09, 10 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C20H24ClN3O2 |
Molar mass | 373.876 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Clebopride |
Articles |
---|
Most recent articles on Clebopride |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Clebopride at Clinical Trials.gov Clinical Trials on Clebopride at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Clebopride
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Clebopride Discussion groups on Clebopride Patient Handouts on Clebopride Directions to Hospitals Treating Clebopride Risk calculators and risk factors for Clebopride
|
Healthcare Provider Resources |
Causes & Risk Factors for Clebopride |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.
A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]
References
- ↑ Cuena Boy R, Maciá Martínez MA (1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]". Atencion Primaria (in Spanish). 21 (5): 289–95. PMID 9608114. Free full text
- Pages with script errors
- CS1 maint: Unrecognized language
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Antiemetics
- Dopamine antagonists
- Motility stimulants
- Piperidines
- Phenol ethers
- Organochlorides
- Drug